U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 7 of 7 results

Status:
US Approved Rx (2007)
First approved in 1999

Class (Stereo):
CHEMICAL (ABSOLUTE)


Conditions:

Orlistat or tetrahydrolipstatin (Xenical, Hoffmann-La Roche) is a saturated derivative of lipstatin originally isolated from Streptomyces toxytricini. Orlistat (Xenical, Hoffmann-La Roche) is a powerful inhibitor of gastrointestinal lipase and as suc...
Status:
US Approved Rx (2015)
First approved in 1960

Class (Stereo):
CHEMICAL (ABSOLUTE)



Benzphetamine is a sympathomimetic agent with properties similar to dextroamphetamine. It is used in the management of exogenous obesity as a short term (a few weeks) adjunct in a regimen of weight reduction based on caloric restriction in patients w...
Status:
US Approved Rx (2016)
First approved in 1959

Class (Stereo):
CHEMICAL (ACHIRAL)


Conditions:

Phentermine is an amphetamine that stimulates neurons to release or maintain high levels of a particular group of neurotransmitters known as catecholamines; these include dopamine and norepinephrine. High levels of these catecholamines tend to suppre...
Status:
US Previously Marketed
First approved in 2012

Class (Stereo):
CHEMICAL (ABSOLUTE)


Conditions:

Lorcaserin, currently marketed under the trade name Belviq and previously Lorqess during development, is a weight-loss drug developed by Arena Pharmaceuticals. Lorcaserin is a selective 5-HT2C receptor agonist, and in vitro testing of the drug showed...
Status:
US Approved Rx (1976)
First approved in 1961

Class (Stereo):
CHEMICAL (ABSOLUTE)



Phendimetrazine is an appetite suppressant that is FDA approved for the treatment of exogenous obesity. It is clinically available anorectic agent, which display minimal interactions with monoamine transporters in vitro. On the other hand, their medi...
Status:
US Approved Rx (2010)
First approved in 1959

Class (Stereo):
CHEMICAL (RACEMIC)



Diethylpropion is a sympathomimetic stimulant drug marketed as an appetite suppressant. Chemically, it is the N,N-diethyl analog of cathinone. Its mechanism of action is similar to other appetite suppressants such as sibutramine, phentermine and dext...
Status:
US Previously Marketed
First approved in 1997

Class (Stereo):
CHEMICAL (RACEMIC)


Conditions:

Subitramine is a potent inhibitor of monoamines (serotonin, dopamine, noradrenaline) reuptake that was approved by FDA for the treatmen of obesity. Sibutramine is metabolized to metabolites M1 and M2 which are more active toward the monoamine transpo...